Trade Gilead GILD

Gilead live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Gilead News

Ava Grace 2025 Sep 04, 05:10

Goldman Sachs: Gold Could Hit $5,000 if Fed Credibility Falters

Ghko B 2025 Sep 03, 16:00

PLTR Stock Prediction: Will Palantir Technologies Stock Keep Going Down?

stocks
Ghko B 2025 Sep 03, 16:00

The Vanguard S&P 500 ETF Is Up: How Is VOO Stock Doing?

etfs stocks
Ghko B 2025 Sep 03, 16:00

Cardano price prediction: How high can Cardano (ADA) price go in 2025?

crypto
Ghko B 2025 Sep 02, 16:00

Crypto stock to watch: Cipher Mining (CIFR) Stock Soars to All-Time High

crypto stocks
Frances Wang 2024 Aug 04, 16:00

The Week Ahead: ISM services, SMCI

CFD Trading
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
Disney is catching up with Netflix
Neil Wilson 2024 Feb 01, 08:03

Week ahead: Earnings season climax

Forex Indices
Consumer inflation
Neil Wilson 2023 Nov 03, 04:01

Week ahead: RBA poised to hike?

Forex Indices
Megacap-tech-stocks.jpg
Neil Wilson 2023 Apr 21, 05:00

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Latest news

Show more
Ava Grace 2025 Sep 04, 07:20

UK Gilts: A Generational Buying Opportunity? Analyzing the Bond Market Surge

Ava Grace 2025 Sep 04, 06:20

Optimus Next Gen: A Glimpse at Tesla's New Gold Robot and Musk's Future Vision

Sophia Claire 2025 Sep 04, 06:20

European Nations Weigh Ukraine Security Pledges Amid Deployment Disagreements

Sophia Claire 2025 Sep 04, 05:20

EU-US Trade Agreement Revamp Threatens Fragile Truce, Sparks Concerns

Ava Grace 2025 Sep 04, 04:20

Gold and Silver Price Swings: Federal Reserve Rate Cut Expectations in Focus

Emma Rose 2025 Sep 04, 03:20

US Congress Standoff: Government Shutdown Looms Amid Blame Game

Ava Grace 2025 Sep 04, 01:20

Fed Beige Book: US Economy Faces Headwinds from Tariffs, Uncertainty

Noah Lee 2025 Sep 04, 01:20

Trump's Fed Nominee Defends Central Bank Independence at Hearing

Info

Spread

0.70

Spread (%)

0.6219 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

139851694080

Shares Outstanding

1240809984

Earnings Date (Next)

2013-01-28

Div Yield

2025-09-29

Ex-Dividend Date

2025-09-15

Forward annual dividend rate

3.16

Forward annual dividend yield

0.028

EPS

5.04

Learn more about this instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Frances Wang 2025 Sep 03, 16:00

Google shares jump: How to trade Alphabet (GOOG) stock CFDs?

Stocks
Frances Wang 2025 Sep 03, 16:00

What is iShares bitcoin Trust ETF IBIT: How to trade IBIT CFDs?

ETFs Crypto CFD Trading
Frances Wang 2025 Sep 02, 16:00

BTC-USD Climbs Back Above $111K: How to Trade Bitcoin CFDs?

Crypto
Trustpilot